Uterine Leiomyomata (Fibroids)

Women's Health
2
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
3 programs
2
PRA-027Phase 11 trial
PRA-027Phase 11 trial
Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 in Japanese N/A1 trial
Active Trials
NCT00826436Completed16Est. Mar 2009
NCT00444704CompletedEst. Dec 2007
NCT00543790Completed48Est. Dec 2008

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerPRA-027
PfizerPRA-027
PfizerStudy Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 in Japanese

Clinical Trials (3)

Total enrollment: 64 patients across 3 trials

Study Evaluating PRA-027 Multiple Ascending Doses In Cycling And Postmenopausal Women

Start: Nov 2007Est. completion: Dec 200848 patients
Phase 1Completed

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females

Start: Mar 2007Est. completion: Dec 2007
Phase 1Completed
NCT00826436PfizerStudy Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 in Japanese

Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 in Japanese Postmenopausal Women

Start: Nov 2008Est. completion: Mar 200916 patients
N/ACompleted

Related Jobs in Women's Health

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space